← Leaderboards
Maksim Royzen
State University Of New York At Albany
$2,556,341
Attributed
$3,776,192
Total exposure
5
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2010–25$2M$1.5M$1M$500K$0
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,776,192 · 5
By mechanism
R44$2,139,478 · 1
R21$1,225,930 · 2
R43$300,224 · 1
F32$110,560 · 1
Top collaborators
- Nathan Yee3 shared
Others in their field
Top investigators on “Design”
- Lawrence Corey · Fred Hutchinson Cancer Center$736,542,541
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- David Heimbrook · Leidos Biomedical Research, Inc.$460,267,569
- Jeffrey P Krischer · University Of South Florida$427,700,530
- David R. Weir · University Of Michigan At Ann Arbor$385,316,144
Research focus
DesignIn VitroTechnologySiteCyclooctenesIn VivoBaseBiologicalSpecificityElementsFda ApprovedFailureDoxorubicinPathologicPharmaceutical PreparationsAntineoplastic AgentsChemistryElectronsModificationMaximum Tolerated DoseDoseAttenuatedPublic HealthToxic Effect
Grant awards (11)
Discovery of solubilizing side chains for in vivo release of diverse drug classes using the Click Activated Protodrugs (CAP) platform$1,209,827
R44 · FY2025 · TR
Discovery of solubilizing side chains for in vivo release of diverse drug classes using the Click Activated Protodrugs (CAP) platform$929,651
R44 · FY2024 · TR
Synthesis and non-chromatographic purification of long RNA oligonucleotides containing naturally occurring modification$193,931
R21 · FY2024 · HG · contact PI
Synthesis and non-chromatographic purification of long RNA oligonucleotides containing naturally occurring modification$193,675
R21 · FY2023 · HG · contact PI
Generalizable Protodrug Characteristics for In Vivo Drug Release using the Click Activated Protodrugs (CAP) Platform$300,224
R43 · FY2022 · TR
Synthesis and non-chromatographic purification of long RNA oligonucleotides containing naturally occurring modification$232,417
R21 · FY2022 · HG · contact PI
Development of Catch and Release Approach for Multi-Drug Local Delivery of Chemotherapies$140,925
R21 · FY2020 · CA · contact PI
Development of Catch and Release Approach for Multi-Drug Local Delivery of Chemotherapies$215,526
R21 · FY2019 · CA · contact PI
Development of Catch and Release Approach for Multi-Drug Local Delivery of Chemotherapies$249,456
R21 · FY2018 · CA · contact PI
Development of blood-brain barrier permeable MRI contrast agents$56,750
F32 · FY2011 · EB · contact PI
Development of blood-brain barrier permeable MRI contrast agents$53,810
F32 · FY2010 · EB · contact PI